Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

• Main Authors: Hejing Bao (Author), Jiani Zhang (Author), Yuhuan Wang (Author), Zhiting Chen (Author), Xi Luo (Author), Ting Li (Author), Haoran Su (Author), Hehong Bao (Author), Xiaolong Cao (Author), Liping Lin (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

We report a case of an advanced non-small cell lung cancer (NSCLC) patient with brain metastasis, RET fusion, and high expression of programmed death ligand 1 (PD-L1) at initial treatment. After receiving radiotherapy for the brain metastasis, the patient started with anlotinib and added immunothera...